Previous 10 | Next 10 |
EDEN PRAIRIE, Minn., March 30, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, today reported fourth quarter and full year 2...
EDEN PRAIRIE, Minn., March 29, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, announced they have moved into a new headquarters co...
EDEN PRAIRIE, Minn., March 17, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced that the Company will report financi...
EDEN PRAIRIE, Minn., March 16, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, announced its participation in CareDx’...
Gainers: Sunshine Biopharma (NASDAQ:SBFM) +183%. Bumble (NASDAQ:BMBL) +42%. Bone Biologics (OTCPK:BBLG) +36%. Cano Health (NYSE:CANO) +35%. CPS Technologies (NASDAQ:CPSH) +29%. AST SpaceMobile (NASDAQ:ASTS) +31%. Hudson Technologies (NASDAQ:HDSN) +30%. FIGS (NYSE:FIGS) +30%. Fluent (NASDAQ:FL...
Miromatrix Medical (NASDAQ:MIRO) appointed Jim Douglas as CFO, effective Mar. 1. Douglas will succeed Brian Niebur, who will continue to serve MIRO as VP of Finance. Douglas joins the Miromatrix team with over 25 years of relevant work experience in investment banking, industry, and public ac...
EDEN PRAIRIE, Minn., March 01, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, announced the appointment of Jim Douglas as t...
EDEN PRAIRIE, Minn., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, announced that the Company will ring the closi...
EDEN PRAIRIE, Minn., Feb. 01, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced its participation in the BTIG MedTech...
EDEN PRAIRIE, Minn., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced the expansion of the board and appoin...
News, Short Squeeze, Breakout and More Instantly...
Miromatrix Medical Inc. Company Name:
MIRO Stock Symbol:
NASDAQ Market:
Miromatrix Medical Inc. Website:
United Therapeutics Corporation (Nasdaq: UTHR ) and Miromatrix Medical Inc. (Nasdaq: MIRO ) announced today that United Therapeutics, through its wholly owned subsidiary Morpheus Subsidiary Inc. (“ Merger Sub ”), has successfully completed the previously announced tender...
United Therapeutics Corporation (Nasdaq: UTHR ) and Miromatrix Medical Inc. (Nasdaq: MIRO ) announced today the results of the previously announced tender offer by Morpheus Subsidiary Inc. (“ Merger Sub ”), a wholly owned subsidiary of United Therapeutics, to acquire all...
NEW YORK, NY / ACCESSWIRE / November 18, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: CapStar Financial Holdings, Inc. ...